Activating autoantibodies and cardiovascular disease

Area of Science:

• Pharmacology
• Immunology
• Cell Biology

Background:

• Stimulating antibodies against various G-protein-coupled receptors (GPCRs) and receptor tyrosine kinases have been documented.
• Examples include antibodies targeting adrenergic receptors (β1, β2, α1) and the angiotensin II AT1 receptor.
• Activating antibodies against the platelet-derived growth factor receptor tyrosine kinase are also established.

Purpose of the Study:

• To review the established existence and actions of stimulating antibodies against key cell surface receptors.
• To identify the current gaps in mechanistic and translational research for these antibodies.

Main Methods:

• Literature review of existing studies on stimulating antibodies.
• Analysis of documented receptor targets and their functions.
• Identification of areas lacking mechanistic and translational investigation.

Main Results:

• The existence and biological actions of stimulating antibodies against GPCRs and receptor tyrosine kinases are supported by existing literature.
• Key examples include antibodies targeting adrenergic receptors and the angiotensin II AT1 receptor.
• The field currently lacks detailed mechanistic studies on how these antibodies activate receptors.

Conclusions:

• While the presence and effects of receptor-stimulating antibodies are recognized, their therapeutic value remains underexplored.
• Further mechanistic studies are required to elucidate receptor activation pathways.
• Translational research is essential to evaluate the potential of these antibodies as therapeutic targets.